Jian Wang et al. npg 527 24 van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregula- tion of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008; 105:13027-13032. 25 Rogler CE, LeVoci L, Ader T, et al. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differen- tiation by targeting Smads. Hepatology 2009; 50:575-584. 26 Chinchilla A, Lozano E, Daimi H, et al. MicroRNA profiling during mouse ventricular maturation: a role for miR-27b mod- ulating Mef2c expression. Cardiovasc Res 2011; 89:98-108. 27 Ren XP, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by target- ing heat-shock protein 20. Circulation 2009; 119:2357-2368. 28 Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF. miR-23a func- tions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA 2009; 106:12103-12108. 29 Wang X, Zhang X, Ren XP, et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010; 122:1308-1318. 30 Hu S, Huang M, Li Z, et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010; 122:S124-S131. 31 Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signaling in fibroblasts. Nature 2008; 465:980-985. 32 Da Costa Martins PA, Salic K, Gladka MM, et al. MicroRNA- 199b targets the nuclear kinase Dyrk1a in an auto-amplifica- tion loop promoting calcineurin/NFAT signaling. Nat Cell Biol 2010; 12:1220-1230. 33 Yamamoto K, Ohki R, Lee RT, Ikeda U, Shimada K. Peroxi- some proliferator-activated receptor γ activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 2001; 104:1670- 1675. 34 Asakawa M, Takano H, Nagai T, et al. Peroxisome prolifer- ator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation 2002; 105:1240-1246. 35 Duan SZ, Ivashchenko CY, Russell MW, Milstone DS, Mortensen RM. Cardiomyocyte-specific knockout and agonist of peroxisome proliferators-activated receptor-γ both induce cardiac hypertrophy in mice. Circ Res 2005; 97:372-379. 36 Ding G, Fu M, Qin Q, et al. Cardiac peroxisome proliferator- activated receptor γ is essential in protecting cardiomyocytes from oxidative damage. Cardiovasc Res 2007; 76:269-279. 37 Jennewein C, Von Knethern A, Schmid T, Brune B. MicroR- NA-27b contributes to lipopolysaccharide-mediated peroxi- some proliferator-activated receptor γ mRNA destabilization. J Biol Chem 2010; 285:11846-11853. 38 Karbiener M, Fischer C, Nowitsch S, et al. MicroRNA miR- 27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 2009; 390:247- 251. 39 Yang X, Li C, Herrera PL, Deng CX. Generation of Smad4/ Dpc4 conditional knockout mice. Genesis 2002; 32:80-81. 40 Murakami M, Nakagawa M, Olson EN, Nakagawa O. A WW domain protein TAZ is a critical coactivator for TBX5, a tran- scription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci USA 2005; 102:18034-18039. 41 Teng Y, Sun AN, Pan XC, et al. Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carci- noma in the mouse. Cancer Res 2006; 66:6972-6981. 42 Hill JA, Karimi M, Kutschke W, et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000; 101:2863-2869. (Supplementary information is linked to the online version of the paper on the Cell Research website.) This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0 www.cell-research.com | Cell Research